Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FFANV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,031
Award facts
- Contract value 100% obligated
- $29,031.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,031.02 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded contract. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Dupixent, a specialty medication used in treating eczema, asthma, and other allergic conditions, aligns with the therapeutic diversity covered under this prime vendor contract, which serves customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates its established capability to fulfill competitive federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FFANV?
SPE2DB25FFANV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FFANV worth?
The government has obligated $29,031 on SPE2DB25FFANV.
Is contract SPE2DB25FFANV an order under another contract?
Yes. SPE2DB25FFANV is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FFANV competed?
The extent of competition for SPE2DB25FFANV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award